Preoperative Management of Jaundice

Savio Barreto, John A. Windsor

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Obstructive jaundice in patients over 40 years old is associated with a 4% risk of
pancreatic cancer, but only 30% of patients with pancreatic cancer present with it
[1]. This fgure rises up to 81% in patients with cancer of the pancreatic head
(Fig. 41.1a) [2]. Obstructive jaundice is a negative risk factor affecting overall survival in pancreatic cancer patients undergoing resection [2].
The management of obstructive jaundice in pancreatic head cancer has evolved
tremendously over the last century. This chapter provides a detailed discussion,
based on available evidence, for the management of obstructive jaundice in patients with pancreatic head cancer.
Original languageEnglish
Title of host publicationTextbook of Pancreatic Cancer
Subtitle of host publicationPrinciples and Practice of Surgical Oncology
EditorsKjetil Soreide, Stefan Stattner
Number of pages18
ISBN (Electronic)978-3-030-53786-9
ISBN (Print)978-3-030-53785-2
Publication statusPublished - 2021


  • Jaundice
  • Drainage
  • Stent
  • Endoscopic percutaneous cholangiography
  • Cholangitis
  • Percutaneous biliary drainag
  • Morbidity
  • Mortality
  • Microbiology
  • Outcomes


Dive into the research topics of 'Preoperative Management of Jaundice'. Together they form a unique fingerprint.

Cite this